Asian Spectator

Times Advertising

Jemincare Announces the Exclusive License of the Kras Inhibito...

  • Written by LATEST ASIANET NEWS RELEASES
  • Published in Asia Net
SHANGHAI, Nov. 30, 2021 /PRNewswire-AsiaNet/ -- Jemincare, a leading pharmaceutical company from China, announced today its wholly owned subsidiary company, Shanghai Jemincare Pharmaceutical Co., Ltd., had licensed exclusive worldwide ex-China rights to the Kras inhibitor, JMKX1899, to HUYABIO ...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Magazine

Why Contractors Suction Hose Solutions Are Essential For Heavy-Duty Fluid Handling

In industries where materials move as relentlessly as time itself, equipment must match that intensity. Whether on construction sites, agricultural operations, or large-scale industrial setups, flui...

Aksi seksisme di ruang digital memiliki pola tersendiri yang bisa kita pahami

Seksime di internet sering kali dianggap sepele karena dianggap sekadar komentar-komentar buruk maupun lelucon yang kasar yang sayangnya kerap dimaklumi sebagai candaan semata. Namun, apa yang tampakn...

Bukan hanya pemilik mobil mewah, dampak kenaikan harga BBM nonsubsidi bakal dirasakan semua orang

● Para pengguna pertamax turbo dan solar nonsubsidi harus gigit jari karena kenaikan harganya sangat tinggi.● Kenaikan harga ini seolah hanya berdampak pada kalangan menengah ke atas.χ...